IAI Accepts, published online ahead of print on 17 March 2008
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carlson, J. H.
Right arrow Articles by Caldwell, H. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carlson, J. H.
Right arrow Articles by Caldwell, H. D.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.00102-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor

John H. Carlson, William M. Whitmire, Deborah D. Crane, Luke Wicke, Kimmo Virtaneva, Daniel E. Sturdevant, John J. Kupko III, Stephen F. Porcella, Neysha Martinez-Orengo, Robert A. Heinzen, Laszlo Kari, and Harlan D. Caldwell*

Laboratory of Intracellular Parasites, and Genomics Unit Research Technologies Section, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, 59840

* To whom correspondence should be addressed. Email: hcaldwell{at}niaid.nih.gov.


arrow
Abstract

Chlamydia trachomatis possess a cryptic 7.5 kb plasmid of unknown function. Here we describe a comprehensive molecular and biological characterization of the naturally occurring plasmidless human C. trachomatis strain L2 (25667R). We found that despite minimal chromosomal polymorphisms the LGV L2 (25667R) strain was indistinguishable from the L2 (434) plasmid positive strain in its in vitro infectivity characteristics such as growth kinetics, plaquing efficiency, and plaque size. The only in vitro phenotypic differences between L2 (434) and L2 (25667R) were the accumulation of glycogen granules in the inclusion matrix and the lack of the typical intra-inclusion Brownian-like movement characteristic of C. trachomatis strains. Conversely, we observed a marked difference between the two strains in their ability to colonize and infect the female mouse genital tract. The ID50 of the L2 (25667R) plasmidless strain was 400 fold greater (4 x 106 IFU) than the L2 (434) plasmid bearing strain (1 x 104 IFU). Transcriptome analysis of the two strains demonstrated a decrease in transcript levels of a subset of chromosomal genes for the L2 (25667R) strain. Among those genes was glgA, encoding glycogen synthase, a finding consistent with the failure of L2 (25667R) to accumulate glycogen granules. These findings support a primary role for the plasmid in in vivo infectivity and suggest virulence is controlled, at least in part, by the plasmid's ability to regulate the expression of chromosomal genes. Our findings have important implications towards understanding a role for the plasmid in the pathogenesis of human infection and disease.